Vision – Mission
CanCOLD (Canadian Cohort of Obstructive Lung Disease) is a prospective multi-center cohort study conducted across Canada, dedicated to increase our understanding on the Chronic Obstructive Pulmonary Disease (COPD) and related co-morbidities, to improve its management and to reduce its burden. This first population based long-term COPD cohort study in Canada is set to end in 2023.
CanCOLD aims to address challenging and important research questions in a more concerted and high-impact fashion by :
- Working together to promote the sharing of common objectives and expertise in COPD research.
- Creating a new research platform for COPD in Canada to leverage future research projects (database, tissue bank, labs and exercise facilities).
- Improving surveillance of COPD in Canada (prevalence, diagnosis, occurrence of disease and progression, risks factors and co-morbidities).
- Assisting public-health and health care system decision makers in developing policies to improve the diagnosis and the management of COPD.
- Optimizing the utilization of health care services at a national, provincial and regional level.
